Moreover, Geserick et al. proposed that strategies to upregulate RIP3 expression may activate the necroptotic signaling machinery in melanoma and that activation of the RIP3/MLKL pathway could be a treatment option for metastatic melanoma20. Here, RIPK3 is linked to melanoma.